| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomes, Human, Y | 14 | 2020 | 148 | 2.910 |
Why?
|
| Lebanon | 38 | 2022 | 227 | 2.390 |
Why?
|
| Haplotypes | 24 | 2020 | 2781 | 2.150 |
Why?
|
| Genetics, Population | 21 | 2021 | 933 | 1.530 |
Why?
|
| DNA, Mitochondrial | 10 | 2018 | 814 | 1.520 |
Why?
|
| Emigration and Immigration | 7 | 2018 | 403 | 1.310 |
Why?
|
| Coronary Artery Disease | 19 | 2023 | 6454 | 1.110 |
Why?
|
| Cholesterol, HDL | 6 | 2024 | 1813 | 1.040 |
Why?
|
| Polymorphism, Single Nucleotide | 31 | 2024 | 15494 | 0.980 |
Why?
|
| Population | 3 | 2020 | 142 | 0.980 |
Why?
|
| Gene Flow | 7 | 2019 | 79 | 0.920 |
Why?
|
| Refugees | 2 | 2023 | 510 | 0.900 |
Why?
|
| Globins | 4 | 2005 | 415 | 0.870 |
Why?
|
| Plasma | 3 | 2020 | 575 | 0.810 |
Why?
|
| Genome, Mitochondrial | 2 | 2018 | 71 | 0.770 |
Why?
|
| Genetic Variation | 19 | 2019 | 6540 | 0.760 |
Why?
|
| History, Ancient | 11 | 2019 | 212 | 0.750 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2023 | 154 | 0.710 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2024 | 11695 | 0.710 |
Why?
|
| Genome-Wide Association Study | 12 | 2024 | 12220 | 0.700 |
Why?
|
| Urine | 1 | 2020 | 370 | 0.670 |
Why?
|
| Sphingomyelins | 1 | 2019 | 105 | 0.660 |
Why?
|
| beta-Thalassemia | 4 | 2005 | 225 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2013 | 3336 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 18 | 2024 | 17400 | 0.570 |
Why?
|
| Population Dynamics | 5 | 2018 | 301 | 0.560 |
Why?
|
| Protein Kinase C-alpha | 1 | 2016 | 112 | 0.550 |
Why?
|
| Women | 1 | 2018 | 230 | 0.540 |
Why?
|
| Metabolomics | 6 | 2020 | 1467 | 0.540 |
Why?
|
| Consanguinity | 6 | 2013 | 456 | 0.530 |
Why?
|
| Phylogeny | 9 | 2018 | 2797 | 0.520 |
Why?
|
| Alleles | 9 | 2024 | 6931 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2014 | 112 | 0.480 |
Why?
|
| Demography | 1 | 2018 | 1650 | 0.440 |
Why?
|
| Coronary Stenosis | 3 | 2021 | 834 | 0.420 |
Why?
|
| Genome, Human | 11 | 2019 | 4420 | 0.420 |
Why?
|
| Phylogeography | 6 | 2019 | 81 | 0.420 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 693 | 0.420 |
Why?
|
| Syria | 4 | 2023 | 75 | 0.410 |
Why?
|
| Aortic Valve | 1 | 2020 | 1911 | 0.380 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2010 | 365 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4414 | 0.360 |
Why?
|
| Evolution, Molecular | 6 | 2020 | 1937 | 0.360 |
Why?
|
| Cholesterol | 1 | 2019 | 2895 | 0.350 |
Why?
|
| Polymorphism, Genetic | 7 | 2021 | 4328 | 0.350 |
Why?
|
| Acculturation | 1 | 2010 | 181 | 0.340 |
Why?
|
| Gene Frequency | 11 | 2017 | 3587 | 0.340 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 361 | 0.340 |
Why?
|
| Anemia, Sickle Cell | 2 | 2010 | 1017 | 0.340 |
Why?
|
| Ectodysplasins | 1 | 2008 | 11 | 0.330 |
Why?
|
| Middle East | 7 | 2016 | 219 | 0.330 |
Why?
|
| Drug Resistance, Viral | 1 | 2014 | 820 | 0.330 |
Why?
|
| RNA, Viral | 4 | 2014 | 2899 | 0.330 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 1941 | 0.320 |
Why?
|
| Communicable Diseases | 1 | 2016 | 878 | 0.310 |
Why?
|
| Male | 67 | 2023 | 349538 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 7 | 2007 | 6171 | 0.310 |
Why?
|
| Ectodermal Dysplasia | 1 | 2008 | 103 | 0.300 |
Why?
|
| Humans | 116 | 2024 | 742088 | 0.300 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 2699 | 0.290 |
Why?
|
| Genotype | 15 | 2017 | 12946 | 0.290 |
Why?
|
| Risk Factors | 29 | 2024 | 72145 | 0.280 |
Why?
|
| Archaeology | 2 | 2018 | 37 | 0.280 |
Why?
|
| Pedigree | 4 | 2020 | 4646 | 0.280 |
Why?
|
| Genetic Loci | 3 | 2023 | 2572 | 0.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 4248 | 0.270 |
Why?
|
| Codon | 2 | 2008 | 611 | 0.260 |
Why?
|
| Proteobacteria | 1 | 2005 | 45 | 0.260 |
Why?
|
| Microsatellite Repeats | 5 | 2020 | 800 | 0.260 |
Why?
|
| Gene Pool | 4 | 2019 | 35 | 0.250 |
Why?
|
| Water Microbiology | 1 | 2005 | 117 | 0.240 |
Why?
|
| Genetic Testing | 4 | 2006 | 3439 | 0.240 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 36 | 0.240 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 1712 | 0.240 |
Why?
|
| DNA, Ribosomal | 1 | 2005 | 289 | 0.240 |
Why?
|
| Water Supply | 1 | 2005 | 214 | 0.230 |
Why?
|
| Fetal Hemoglobin | 2 | 2003 | 341 | 0.230 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2556 | 0.230 |
Why?
|
| Chromosome Disorders | 1 | 2006 | 515 | 0.220 |
Why?
|
| Seafood | 1 | 2006 | 384 | 0.220 |
Why?
|
| Middle Aged | 33 | 2023 | 213127 | 0.220 |
Why?
|
| Female | 51 | 2023 | 379592 | 0.220 |
Why?
|
| Africa, Northern | 6 | 2019 | 82 | 0.210 |
Why?
|
| Thalassemia | 1 | 2003 | 273 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2021 | 9 | 0.210 |
Why?
|
| China | 6 | 2022 | 2246 | 0.210 |
Why?
|
| Adult | 39 | 2023 | 213712 | 0.200 |
Why?
|
| Odds Ratio | 6 | 2021 | 9846 | 0.200 |
Why?
|
| Phenotype | 10 | 2017 | 16331 | 0.200 |
Why?
|
| Lipoprotein(a) | 1 | 2005 | 425 | 0.200 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 926 | 0.190 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 732 | 0.190 |
Why?
|
| Mediterranean Region | 2 | 2018 | 47 | 0.190 |
Why?
|
| Mutation | 9 | 2013 | 29717 | 0.190 |
Why?
|
| Geography | 5 | 2015 | 669 | 0.190 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 115 | 0.190 |
Why?
|
| Africa | 5 | 2019 | 670 | 0.190 |
Why?
|
| Nicotine | 1 | 2005 | 677 | 0.190 |
Why?
|
| Spain | 2 | 2019 | 465 | 0.190 |
Why?
|
| Fruit | 1 | 2006 | 1139 | 0.190 |
Why?
|
| Cresols | 1 | 2020 | 28 | 0.180 |
Why?
|
| Hepacivirus | 1 | 2007 | 1372 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 250 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5867 | 0.180 |
Why?
|
| Coronary Restenosis | 1 | 2023 | 424 | 0.180 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 1465 | 0.180 |
Why?
|
| Rural Population | 4 | 2022 | 2207 | 0.180 |
Why?
|
| Nepovirus | 2 | 1996 | 2 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2638 | 0.180 |
Why?
|
| Asthma | 2 | 2016 | 5955 | 0.170 |
Why?
|
| Europe | 10 | 2017 | 3339 | 0.170 |
Why?
|
| Population Density | 3 | 2019 | 194 | 0.170 |
Why?
|
| Cultural Characteristics | 1 | 2020 | 262 | 0.170 |
Why?
|
| Smoking | 3 | 2017 | 8969 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 451 | 0.170 |
Why?
|
| Genetic Linkage | 5 | 2017 | 2422 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2020 | 6249 | 0.160 |
Why?
|
| Bible | 1 | 2018 | 5 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5304 | 0.160 |
Why?
|
| Urinalysis | 1 | 2020 | 369 | 0.160 |
Why?
|
| Age of Onset | 5 | 2013 | 3266 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 284 | 0.160 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2002 | 385 | 0.160 |
Why?
|
| Italy | 2 | 2018 | 828 | 0.150 |
Why?
|
| Asia | 6 | 2017 | 607 | 0.150 |
Why?
|
| Influenza in Birds | 1 | 2018 | 75 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2007 | 1582 | 0.150 |
Why?
|
| Chromosomes, Human, X | 2 | 2016 | 296 | 0.150 |
Why?
|
| Leptin | 2 | 2002 | 1593 | 0.150 |
Why?
|
| Case-Control Studies | 7 | 2021 | 21719 | 0.150 |
Why?
|
| Adolescent | 15 | 2019 | 85649 | 0.150 |
Why?
|
| Exons | 3 | 2008 | 2431 | 0.150 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2018 | 113 | 0.150 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1232 | 0.140 |
Why?
|
| Tunisia | 1 | 2016 | 33 | 0.140 |
Why?
|
| Cyprus | 1 | 2016 | 78 | 0.140 |
Why?
|
| Medical Records | 1 | 2002 | 1413 | 0.140 |
Why?
|
| Periodontitis | 1 | 2021 | 553 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2018 | 1472 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2003 | 983 | 0.140 |
Why?
|
| Osteoporosis | 2 | 2022 | 1581 | 0.140 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 1586 | 0.140 |
Why?
|
| Factor V | 2 | 2010 | 174 | 0.140 |
Why?
|
| Tooth | 1 | 2018 | 207 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11690 | 0.140 |
Why?
|
| HIV-1 | 1 | 2014 | 6934 | 0.140 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 68 | 0.140 |
Why?
|
| Sentinel Surveillance | 1 | 2018 | 281 | 0.140 |
Why?
|
| HLA-DQ Antigens | 3 | 2009 | 210 | 0.130 |
Why?
|
| Chickens | 1 | 2018 | 865 | 0.130 |
Why?
|
| Constriction, Pathologic | 3 | 2023 | 1095 | 0.130 |
Why?
|
| Viral Core Proteins | 1 | 1996 | 162 | 0.130 |
Why?
|
| Africa South of the Sahara | 3 | 2019 | 724 | 0.130 |
Why?
|
| Bone Density | 2 | 2022 | 3469 | 0.130 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 628 | 0.130 |
Why?
|
| Papillomaviridae | 1 | 2002 | 1118 | 0.130 |
Why?
|
| Prevalence | 7 | 2014 | 15194 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2023 | 848 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.130 |
Why?
|
| Aged | 23 | 2024 | 162944 | 0.130 |
Why?
|
| Arabs | 1 | 2017 | 177 | 0.130 |
Why?
|
| tRNA Methyltransferases | 1 | 2014 | 53 | 0.130 |
Why?
|
| Pancreas | 1 | 2021 | 1684 | 0.120 |
Why?
|
| Lipoproteins, HDL | 1 | 2019 | 637 | 0.120 |
Why?
|
| Coronary Angiography | 3 | 2015 | 4567 | 0.120 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2005 | 768 | 0.120 |
Why?
|
| Cholesterol, LDL | 3 | 2019 | 2354 | 0.120 |
Why?
|
| Reverse Transcription | 1 | 2014 | 47 | 0.120 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 166 | 0.120 |
Why?
|
| HIV Protease | 1 | 2014 | 96 | 0.120 |
Why?
|
| Amyloidosis, Familial | 1 | 2013 | 13 | 0.120 |
Why?
|
| Culture | 1 | 2018 | 632 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5724 | 0.120 |
Why?
|
| Bioartificial Organs | 1 | 2013 | 49 | 0.110 |
Why?
|
| Alstrom Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cultural Evolution | 1 | 2013 | 9 | 0.110 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2014 | 213 | 0.110 |
Why?
|
| Cluster Analysis | 4 | 2016 | 2713 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2021 | 1368 | 0.110 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2013 | 80 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 4801 | 0.110 |
Why?
|
| Base Sequence | 7 | 2017 | 12797 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2020 | 6452 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 3510 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 380 | 0.100 |
Why?
|
| Young Adult | 10 | 2021 | 56350 | 0.100 |
Why?
|
| Principal Component Analysis | 4 | 2017 | 939 | 0.100 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 1486 | 0.100 |
Why?
|
| Hyperhomocysteinemia | 1 | 2012 | 124 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2203 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7873 | 0.100 |
Why?
|
| Caffeine | 1 | 2015 | 699 | 0.100 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2010 | 29 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2008 | 2633 | 0.090 |
Why?
|
| Interferon-alpha | 2 | 2007 | 895 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2015 | 1074 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 959 | 0.090 |
Why?
|
| Fertility Agents, Female | 1 | 2010 | 99 | 0.090 |
Why?
|
| Inflammation | 2 | 2023 | 10578 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2857 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 1585 | 0.090 |
Why?
|
| Milk | 2 | 2003 | 449 | 0.090 |
Why?
|
| Cost of Illness | 2 | 2018 | 1852 | 0.090 |
Why?
|
| Population Groups | 1 | 2010 | 208 | 0.090 |
Why?
|
| Infection Control | 1 | 2016 | 962 | 0.090 |
Why?
|
| Mediterranean Sea | 1 | 2008 | 12 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 2 | 2009 | 185 | 0.080 |
Why?
|
| Child | 11 | 2018 | 77478 | 0.080 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 4742 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 281 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2018 | 40955 | 0.080 |
Why?
|
| Wolfram Syndrome | 1 | 2008 | 13 | 0.080 |
Why?
|
| Stroke | 2 | 2022 | 9963 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 641 | 0.080 |
Why?
|
| Homocysteine | 1 | 2012 | 647 | 0.080 |
Why?
|
| Body Height | 1 | 2015 | 1574 | 0.080 |
Why?
|
| Cohort Studies | 6 | 2022 | 40450 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 1768 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1727 | 0.080 |
Why?
|
| Streptococcus agalactiae | 1 | 2010 | 375 | 0.080 |
Why?
|
| Diet | 1 | 2006 | 7923 | 0.080 |
Why?
|
| Drug Costs | 1 | 2016 | 1104 | 0.080 |
Why?
|
| Echocardiography | 1 | 2020 | 5097 | 0.080 |
Why?
|
| Isotretinoin | 1 | 2008 | 109 | 0.080 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 24913 | 0.080 |
Why?
|
| Behcet Syndrome | 1 | 2008 | 84 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1411 | 0.080 |
Why?
|
| HIV Infections | 1 | 2014 | 16678 | 0.080 |
Why?
|
| Brucellosis | 1 | 2007 | 20 | 0.080 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2007 | 30 | 0.080 |
Why?
|
| Biotinidase Deficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 1899 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12242 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1152 | 0.070 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 101 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 4664 | 0.070 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2007 | 140 | 0.070 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2006 | 66 | 0.070 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 102 | 0.070 |
Why?
|
| Heterozygote | 3 | 2016 | 2790 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2010 | 482 | 0.070 |
Why?
|
| Language | 2 | 2015 | 1458 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2006 | 230 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2008 | 4024 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2006 | 199 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2006 | 245 | 0.070 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2005 | 17 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 637 | 0.070 |
Why?
|
| Monophenol Monooxygenase | 1 | 2005 | 69 | 0.070 |
Why?
|
| Proviruses | 1 | 2007 | 316 | 0.060 |
Why?
|
| Logistic Models | 4 | 2016 | 13403 | 0.060 |
Why?
|
| Cotinine | 1 | 2005 | 206 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2016 | 23320 | 0.060 |
Why?
|
| Algorithms | 3 | 2019 | 13853 | 0.060 |
Why?
|
| Zidovudine | 1 | 2007 | 620 | 0.060 |
Why?
|
| Hypertension | 3 | 2021 | 8455 | 0.060 |
Why?
|
| Dermatologic Agents | 1 | 2008 | 274 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2015 | 0.060 |
Why?
|
| Infant | 6 | 2021 | 35070 | 0.060 |
Why?
|
| Iran | 3 | 2015 | 704 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2016 | 1895 | 0.060 |
Why?
|
| Ethiopia | 2 | 2016 | 494 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2010 | 2500 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1086 | 0.060 |
Why?
|
| Depression | 1 | 2023 | 7733 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 427 | 0.060 |
Why?
|
| Hemoglobin A2 | 1 | 2003 | 5 | 0.060 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2003 | 73 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 173 | 0.060 |
Why?
|
| Health Personnel | 1 | 2016 | 3210 | 0.060 |
Why?
|
| Hemoglobin A | 1 | 2003 | 87 | 0.060 |
Why?
|
| Family Health | 2 | 2010 | 1282 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2003 | 46 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2016 | 2346 | 0.050 |
Why?
|
| Birth Order | 1 | 2003 | 95 | 0.050 |
Why?
|
| Homozygote | 2 | 2004 | 1777 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2006 | 305 | 0.050 |
Why?
|
| Arsenicals | 1 | 2003 | 124 | 0.050 |
Why?
|
| Health | 1 | 2005 | 390 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4751 | 0.050 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2003 | 93 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2017 | 6078 | 0.050 |
Why?
|
| Syndrome | 1 | 2008 | 3248 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 497 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2017 | 1995 | 0.050 |
Why?
|
| Streptozocin | 1 | 2021 | 193 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 18112 | 0.050 |
Why?
|
| Anthropometry | 1 | 2006 | 1350 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 947 | 0.050 |
Why?
|
| Drinking | 1 | 2002 | 197 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 57683 | 0.050 |
Why?
|
| Oxides | 1 | 2003 | 405 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1624 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2022 | 418 | 0.050 |
Why?
|
| Antiviral Agents | 2 | 2018 | 2978 | 0.050 |
Why?
|
| Species Specificity | 1 | 2005 | 2479 | 0.050 |
Why?
|
| Y Chromosome | 1 | 2001 | 206 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2013 | 4393 | 0.050 |
Why?
|
| Comorbidity | 1 | 2014 | 10372 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2017 | 3493 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2006 | 1726 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 655 | 0.050 |
Why?
|
| Gallbladder | 1 | 2021 | 301 | 0.050 |
Why?
|
| Organogenesis | 1 | 2021 | 222 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2008 | 2036 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15108 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 12705 | 0.040 |
Why?
|
| Fossils | 1 | 2019 | 76 | 0.040 |
Why?
|
| Multigene Family | 1 | 2003 | 1102 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 1656 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2021 | 350 | 0.040 |
Why?
|
| Animals | 9 | 2023 | 168561 | 0.040 |
Why?
|
| Fasting | 1 | 2005 | 1589 | 0.040 |
Why?
|
| Fabaceae | 2 | 1996 | 103 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2002 | 511 | 0.040 |
Why?
|
| Plants, Medicinal | 2 | 1996 | 167 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2021 | 12695 | 0.040 |
Why?
|
| Premature Birth | 1 | 2010 | 1713 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10232 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2010 | 2026 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2003 | 2295 | 0.040 |
Why?
|
| Proteins | 1 | 2013 | 6096 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2018 | 75 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 570 | 0.040 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 89 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 527 | 0.040 |
Why?
|
| Triglycerides | 2 | 2015 | 2450 | 0.040 |
Why?
|
| Chad | 1 | 2016 | 8 | 0.040 |
Why?
|
| Seasons | 1 | 2003 | 1492 | 0.040 |
Why?
|
| Postmenopause | 1 | 2006 | 2461 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 19862 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 1916 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1767 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2018 | 8297 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2002 | 1382 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 707 | 0.040 |
Why?
|
| Ribonuclease H | 1 | 1996 | 45 | 0.040 |
Why?
|
| Greece | 1 | 2017 | 344 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1296 | 0.040 |
Why?
|
| Armenia | 1 | 2015 | 17 | 0.030 |
Why?
|
| Probability | 1 | 2002 | 2502 | 0.030 |
Why?
|
| Neoplasms | 2 | 2016 | 21596 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2014 | 1780 | 0.030 |
Why?
|
| Age Distribution | 1 | 2002 | 2900 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3502 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2018 | 379 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2015 | 91 | 0.030 |
Why?
|
| Aryldialkylphosphatase | 1 | 2015 | 63 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4187 | 0.030 |
Why?
|
| Sex Factors | 2 | 2015 | 10392 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2224 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15530 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2003 | 1339 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 708 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77098 | 0.030 |
Why?
|
| Dyspnea | 1 | 2022 | 1298 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 795 | 0.030 |
Why?
|
| Rats | 2 | 2021 | 24265 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5238 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1190 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 2714 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 457 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2001 | 983 | 0.030 |
Why?
|
| Leukotrienes | 1 | 2015 | 255 | 0.030 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2013 | 19 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 419 | 0.030 |
Why?
|
| Ketosis | 1 | 2013 | 49 | 0.030 |
Why?
|
| Agriculture | 1 | 2014 | 187 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2020 | 1166 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 846 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1889 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 1844 | 0.030 |
Why?
|
| Incidence | 3 | 2010 | 20928 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13655 | 0.030 |
Why?
|
| Morocco | 1 | 2012 | 28 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Afghanistan | 1 | 2012 | 81 | 0.030 |
Why?
|
| Asia, Central | 1 | 2011 | 12 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2488 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 469 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2417 | 0.030 |
Why?
|
| Vitamins | 1 | 2020 | 1608 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2011 | 111 | 0.030 |
Why?
|
| Software | 1 | 2006 | 4434 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3800 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 969 | 0.030 |
Why?
|
| Pregnancy | 3 | 2010 | 29087 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 2013 | 388 | 0.020 |
Why?
|
| Health Surveys | 1 | 2002 | 4030 | 0.020 |
Why?
|
| Organic Anion Transporters | 1 | 2012 | 100 | 0.020 |
Why?
|
| Flucytosine | 1 | 2010 | 32 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2366 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2010 | 1320 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 759 | 0.020 |
Why?
|
| Coffee | 1 | 2015 | 578 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1803 | 0.020 |
Why?
|
| Linguistics | 1 | 2011 | 96 | 0.020 |
Why?
|
| Internationality | 1 | 2016 | 1002 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 25575 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2003 | 2933 | 0.020 |
Why?
|
| Russia | 1 | 2011 | 409 | 0.020 |
Why?
|
| Turkey | 1 | 2010 | 237 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3133 | 0.020 |
Why?
|
| DNA | 1 | 2004 | 7289 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 2866 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 786 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2002 | 3278 | 0.020 |
Why?
|
| Lipids | 1 | 2021 | 3302 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2013 | 368 | 0.020 |
Why?
|
| Serotyping | 1 | 2010 | 338 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2303 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39004 | 0.020 |
Why?
|
| Protons | 1 | 2015 | 1126 | 0.020 |
Why?
|
| Data Mining | 1 | 2014 | 537 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15056 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 140 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 591 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3335 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 279 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 501 | 0.020 |
Why?
|
| Insulin | 1 | 2002 | 6575 | 0.020 |
Why?
|
| Pain | 1 | 2003 | 4961 | 0.020 |
Why?
|
| Genomics | 2 | 2015 | 5692 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7721 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7141 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1599 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 53187 | 0.020 |
Why?
|
| Virus Replication | 1 | 1995 | 2531 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9410 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 508 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1385 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2885 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3099 | 0.020 |
Why?
|
| Time Factors | 3 | 2017 | 40054 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1983 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2010 | 591 | 0.020 |
Why?
|
| Hematuria | 1 | 2006 | 235 | 0.020 |
Why?
|
| RNA | 1 | 1995 | 2747 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3760 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2013 | 2520 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 854 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11470 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2013 | 1205 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10472 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1707 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 13814 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 211 | 0.010 |
Why?
|
| Gene Products, tax | 1 | 2003 | 51 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20774 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3585 | 0.010 |
Why?
|
| Computational Biology | 1 | 2015 | 3518 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3062 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8328 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 399 | 0.010 |
Why?
|
| Blood Donors | 1 | 2004 | 355 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11472 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 188 | 0.010 |
Why?
|
| Gestational Age | 1 | 2010 | 3490 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3444 | 0.010 |
Why?
|
| Trisomy | 1 | 2003 | 266 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2010 | 2041 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 462 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 1243 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2003 | 433 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23387 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 563 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2795 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3861 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 1179 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 81045 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1583 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3611 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15994 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
| Viral Load | 1 | 2007 | 3292 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1378 | 0.010 |
Why?
|
| Albuminuria | 1 | 2001 | 683 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7770 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6483 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2751 | 0.010 |
Why?
|
| RNA, Satellite | 1 | 1995 | 17 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6365 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6313 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6756 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4929 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16665 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 2536 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 2616 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2455 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 433 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5872 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14720 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 914 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 29010 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 62966 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 35342 | 0.000 |
Why?
|